Oral paliperidone for schizophrenia-Reference-Cited by-同舟云学术

Oral paliperidone for schizophrenia

Published:2008-04-23 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Nussbaum Abraham M¹,Stroup T S²

Affiliation:

1. Denver Health; Behavioral Health Service; MC 0490 777 Bannock Street Denver CO USA 80204

2. Columbia University; Psychiatry; 1051 Riverside Drive Room 2703, Box 100 New York New York USA 10032

Publisher

Wiley

Subject

Pharmacology (medical)

Reference146 articles.

1. Canuso C Carothers J Dirks B Zhu Y Kosik-Gonzalez C A double-blind placebo-controlled trial comparing paliperidone ER and quetiapine in patients with a recent acute exacerbation of schizophrenia Proceedings of the 161st Annual Meeting of the American Psychiatric Association; 2008 May 3-6; Washington DC Washington, DC 2008

2. A double-blind placebo-controlled trial comparing paliperidone er and quetiapine in patients with a recent acute exacerbation of schizophrenia;Canuso;Schizophrenia Research,2008

3. Canuso C Dirks B Carothers J Zhu T Kosik-Gonzalez C A double-blind, placebo-controlled trial of paliperidone er and quetiapine in patients with a recent acute exacerbation of schizophrenia Proceedings of the 20th Annual U.S. Psychiatric & Mental Health Congress; 2007 11-14 Oct; Orlando, Florida Orlando, Florida 2007

4. A comparative analysis of paliperidone er and quetiapine in patients with a recent, acute exacerbation of schizophrenia;Canuso;Schizophrenia Research,2008

5. Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia;Canuso;American Journal of Psychiatry,2009

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in representative small-molecule DRD2 inhibitors: Synthetic Routes and clinical applications;European Journal of Medicinal Chemistry;2024-11

2. An umbrella review of adverse effects associated with antipsychotic medications: the need for complementary study designs;Neuroscience & Biobehavioral Reviews;2023-12

3. Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports;BMC Medicine;2021-08-25

4. Schizophrenia Treatment with Second-Generation Antipsychotics: A Multi-Country Comparison of the Costs of Cardiovascular and Metabolic Adverse Events and Weight Gain;Neuropsychiatric Disease and Treatment;2021-01

5. Adverse Drug Reaction Risk Measures: A Comparison of Estimates from Drug Surveillance and Randomised Trials;Pharmaceutical Medicine;2019-06-15